|
2 Companies |
|
2 Products |
|
2 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
5 News |
|
- Avastin (bevacizumab) / Roche
Trial completion, Enrollment change, Trial primary completion date: Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors (clinicaltrials.gov) - Sep 30, 2016
P0, N=6, Completed, Sponsor: Washington University School of Medicine
Recruiting --> Completed | N=10 --> 6 | Trial primary completion date: Jan 2017 --> May 2016
- Avastin (bevacizumab) / Roche
Trial primary completion date: Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors (clinicaltrials.gov) - Jul 20, 2015
P0, N=5, Recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Completed | N=10 --> 6 | Trial primary completion date: Jan 2017 --> May 2016 Trial primary completion date: Jun 2015 --> Jan 2017
- Avastin (bevacizumab) / Roche
Trial primary completion date: Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors (clinicaltrials.gov) - May 14, 2014
P0, N=5, Recruiting, Sponsor: Washington University School of Medicine
Trial primary completion date: Jun 2015 --> Jan 2017 Trial primary completion date: Apr 2014 --> Jun 2015
- Avastin (bevacizumab) / Roche
Enrollment open: Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors (clinicaltrials.gov) - Dec 1, 2013
P0, N=5, Recruiting, Sponsor: Washington University School of Medicine
Trial primary completion date: Apr 2014 --> Jun 2015 Not yet recruiting --> Recruiting